Premier Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,495
Closed -$913K 60
2022
Q4
$913K Buy
2,495
+650
+35% +$230K 1.15% 25
2022
Q3
$597K Buy
1,845
+1,060
+135% +$336K 0.62% 45
2022
Q2
$259K Buy
+785
New +$236K 0.21% 74
2016
Q2
Sell
-4,350
Closed -$313K 99
2016
Q1
$313K Hold
4,350
0.08% 78
2015
Q4
$366K Sell
4,350
-25
-0.6% -$2.08K 0.09% 70
2015
Q3
$366K Hold
4,375
0.09% 70
2015
Q2
$365K Hold
4,375
0.09% 72
2015
Q1
$317K Sell
4,375
-350
-7% -$24.9K 0.07% 86
2014
Q4
$325K Sell
4,725
-75
-2% -$5.06K 0.08% 77
2014
Q3
$311K Sell
4,800
-125
-3% -$7.91K 0.08% 80
2014
Q2
$306K Hold
4,925
0.08% 84
2014
Q1
$289K Sell
4,925
-100
-2% -$5.58K 0.08% 84
2013
Q4
$256K Hold
5,025
0.07% 85
2013
Q3
$252K Buy
+5,025
New +$263K 0.07% 85

Other funds holding LLY

Premier Asset Management's LLY Position: Q1 2023 in Review

Premier Asset Management sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 2,495 shares — an estimated $913K sold.

Premier Asset Management first reported a position in LLY in Q3 2013 and held it in 14 quarters. The position peaked at $913K in Q4 2022. 2,614 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Premier Asset Management reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Premier Asset Management sold 2,495 Eli Lilly shares in Q1 2023, an estimated $913K.
  • Premier Asset Management first reported a position in Eli Lilly in Q3 2013 and held it in 14 quarters.
  • Premier Asset Management's Eli Lilly position peaked at $913K in Q4 2022.
  • 2,614 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Premier Asset Management's 13F filing for Q1 2023.